Warrants (Details) - Common Stock Warrants - $ / shares |
3 Months Ended | 12 Months Ended |
|---|---|---|
Mar. 31, 2024 |
Dec. 31, 2023 |
|
| Number of Common Shares Issuable Upon Exercise of Outstanding Warrants | ||
| Outstanding at beginning of year (in shares) | 13,064,299 | |
| Issued (in shares) | 60,728,829 | |
| Exercised (in shares) | (2,750,557) | |
| Outstanding at end of year (in shares) | 71,042,571 | 13,064,299 |
| Weighted Average Exercise Price | ||
| Outstanding at beginning of year (in usd per share) | $ 2.40 | |
| Issued (in usd per share) | 0.49 | |
| Exercised (in usd per share) | 0.52 | |
| Outstanding at end of year (in usd per share) | $ 0 | $ 2.40 |
| Weighted Average Remaining Term in Years | ||
| Outstanding | 5 years 3 months 10 days | 2 years 5 months 4 days |
| Issued | 5 years 11 months 4 days |
| X | ||||||||||
- Definition Class Of Warrant Or Right, Number Of Awards No definition available.
|
| X | ||||||||||
- Definition Class Of Warrant Or Right, Weighted Average Exercise Price No definition available.
|
| X | ||||||||||
- Definition Class Of Warrant Or Right, Weighted Average Remaining Contractual Term No definition available.
|
| X | ||||||||||
- Definition The weighted average exercise price of granted awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units. No definition available.
|
| X | ||||||||||
- Definition The weighted average exercise price of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units. No definition available.
|
| X | ||||||||||
- Definition The weighted average exercise price of Vested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options granted, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|